The Architecture of Curation: Scaling Cultural Premium and Bio-Scientific Wellness.

VF Group operates an institutional asset growth holding corporate across the Asia-Pacific. We engineer premium, defensible market positioning by governing a diverse ecosystem of specialized platforms, seamlessly cross-linking avant-garde fashion curation with clinically-driven han-biotech infrastructures. Through structured enterprise governance, we scale long-term corporate value.

+
Years Of Experience
+
Retail Points
%
Customer Satisfaction

Driving defensible scale and narrative-led commercial transformation across premium retail and biomedical wellness sectors.

THE DUAL-ENGINE HOLDING CORPORATE

We operate as a high-level corporate governing body at the intersection of emotional premium and rigid scientific moats. By anchoring exclusive luxury lifestyle platforms alongside institutional clinical wellness networks under our unified corporate umbrella, we provide global partners with unshakeable market relevance and highly scalable growth.

Wil See

Executive Board

OUR SUBSIDIARY PLATFORMS & CAPITAL PILLARS

01.

PRECISION FASHION CURATION

Exclusive regional distribution and asset scaling of avant-garde lifestyle portfolios including Anglan, Tacs Watch and Colonist.

02.

CLINICAL HAN-BIOTECH

R&D-driven biomedical wellness powered by our flagship brand HAE, deeply integrated across an expansive network of 300+ modern TCM clinic groups.

03.

SCALABLE MARKET INFRASTRUCTURE

Cross-border infrastructure and structural commercial systems creating sustainable moats and premium evaluation for global institutional scale.

PARTNER WITH THE FUTURE OF COMMERCE

Connect with our corporate development team to explore strategic allocations, joint ventures, and institutional partnerships for our 2026–2028 roadmap.

OUR INSTITUTIONAL ADVANTAGES

Cultural Premium Curation

We identify and weaponize high-affinity lifestyle narratives that command immense pricing power and generational brand loyalty.

Scientific Defensibility

Backed by proprietary molecular bio-extraction technology and solid patent pipelines protecting our healthcare assets.

Omnichannel Domination

Unrivaled placement across top-tier clinical networks, digital ecosystems, and key physical storefronts in Taiwan, Korea, and Hong Kong/Macau.

PARTNER & INSTITUTIONAL TRUST

THE VISUAL PROSPECTUS OF TRANSFORMATION

Scroll to Top